Traitement conventionnel du myélome multiple = Standard chemotherapy for multiple myelomaFACON, T.La Revue de médecine interne (Paris). 1999, Vol 20, Num 7, pp 611-621, issn 0248-8663Article

Traitement conventionnel du myélome multiple = Standard chemotherapy for multiple myelomaFACON, T.Hématologie (Montrouge). 1997, Vol 3, Num 3, pp 245-255, issn 1264-7527Article

Le traitement de première intention des épisodes fébriles chez les neutropéniques = First-line treatment of febrile episodes in patients with neutropeniaJOUET, J. P; FACON, T.Réanimation, soins intensifs, médecine d'urgence. 1992, Vol 8, Num 4, pp 231-235, issn 0765-5290Article

Le traitement du myélome chez le sujet âgé = Treatment of myeloma in the elderlyFACON, T.Oncologie (Paris). 2002, Vol 4, Num 2, pp 106-110, issn 1292-3818Article

Le traitement de première intention des épisodes fébriles chez les neutropéniques = First-line treatment of febrile episodes in patients with neutropeniaJOUET, J. P; FACON, T.La Semaine des hôpitaux de Paris. 1992, Vol 68, Num 18, pp 535-539, issn 0037-1777Article

Traitement du myélome multiple : Hématologie maligne = Treating multiple myelomaCOITEUX, V; TRICOT, S; WEMEAU, M et al.Oncologie (Paris). 2006, Vol 8, Num 4, pp 357-361, issn 1292-3818, 5 p.Article

Multiple myeloma : Almost all patients are cytogenetically abnormalZANDECKI, M; LAÏ, J.-L; FACON, T et al.British journal of haematology. 1996, Vol 94, Num 2, pp 217-227, issn 0007-1048Article

Lenalidomide in the treatment of multiple myeloma : a reviewARMOIRY, X; AULAGNER, G; FACON, T et al.Journal of clinical pharmacy and therapeutics (Print). 2008, Vol 33, Num 3, pp 219-226, issn 0269-4727, 8 p.Article

Leucémie myéloïde chronique = Chronic myeloid leukemiaFACON, T.Hématologie (Montrouge). 2000, Vol 6, pp 19-22, issn 1264-7527, NSArticle

Myélome multiple = Multiple myelomaFACON, T.Hématologie (Montrouge). 2000, Vol 6, pp 13-18, issn 1264-7527, NSArticle

Phase I study of the anti insulin-like growth factor 1 receptor (IGF-1R) monoclonal antibody, AVE1642, as single agent and in combination with bortezomib in patients with relapsed multiple myelomaMOREAU, P; CAVALLO, F; LELEU, X et al.Leukemia. 2011, Vol 25, Num 5, pp 872-874, issn 0887-6924, 3 p.Article

Renouveau des traitements d'entretien dans le myélome multiple: place des immunomodulateurs (IMiDs) : Actualités en hématologie = Advances in maintenance treatment in multiple myeloma: the place of immunomodulators (IMiDs) : Progress in haematologyMANIER, S; BOYLE, E; GAUTHIER, J et al.Oncologie (Paris). 2011, Vol 13, Num 9, pp 553-558, issn 1292-3818, 6 p.Article

Nilotinib is active in chronic and accelerated phase chronic myeloid leukemia following failure of imatinib and dasatinib therapyGILES, F. J; ABRUZZESE, E; FISCHER, T et al.Leukemia. 2010, Vol 24, Num 7, pp 1299-1301, issn 0887-6924, 3 p.Article

Coexistence of AML1/RUNX1 and BCR-ABL point mutations in an imatinib-resistant form of CMLCORM, S; BIGGIO, V; ROCHE-LESTIENNE, C et al.Leukemia. 2005, Vol 19, Num 11, pp 1991-1992, issn 0887-6924, 2 p.Article

Bone marrow endothelial cells increase the invasiveness of human multiple myeloma cells through upregulation of MMp-9: evidence for a role of hepatocyte growth factorVANDE BROEK, I; ASOSINGH, K; ALLEGAERT, V et al.Leukemia. 2004, Vol 18, Num 5, pp 976-982, issn 0887-6924, 7 p.Article

Manifestations cutanéo-muqueuses des infections à herpes simplex virus et virus de la varicelle zona chez les immunodéprimés VIH-négatifs : à propos de six cas = Cutaneous and mucosal manifestations related to herpes simplex virus and varicella-zoster virus affections in the HIV seronegative immunocompromised patientsCATTEAU, B; HOUCKE, C; PIETTE, F et al.Les Nouvelles dermatologiques. 1999, Vol 18, Num 3, issn 0752-5370, p. 187Conference Paper

Cytogenetics in multiple myeloma : A multicenter study of 24 patients with t(11;14)(q13;q32) or its variantLAÏ, J. L; MICHAUX, L; DASTUGUE, N et al.Cancer genetics and cytogenetics. 1998, Vol 104, Num 2, pp 133-138, issn 0165-4608Article

Involvement of TNF-alpha secreting macrophages in lethal forms of human graft-versus-host diseaseFACON, T; JOUET, J. P; NOEL-WALTER, M. P et al.Bone marrow transplantation (Basingstoke). 1997, Vol 20, Num 6, pp 511-515, issn 0268-3369Article

Adhesive interations between tumour cells and bone marrow stromal elements in human multiple myelomaFAID, L; VAN RIET, I; DE WAELE, M et al.European journal of haematology. 1996, Vol 57, Num 5, pp 349-358, issn 0902-4441Article

Improved cytogenetic analysis of bone marrow plasma cells after cytokine stimulation in multiple myeloma : a report on 46 patientsFACON, T; LAI, J. L; NATAF, E et al.British journal of haematology. 1993, Vol 84, Num 4, pp 743-745, issn 0007-1048Article

Acute monocytic leukemia with (8;22)(p11;q13) translocation : involvement of 8p11 as in classical t(8;16)(p11;p13)LAI, J. L; ZANDECKI, M; FENAUX, P et al.Cancer genetics and cytogenetics. 1992, Vol 60, Num 2, pp 180-182, issn 0165-4608Article

Simultaneous occurrence of grey platelet syndrome and idiopathic pulmonary fibrosis : a role for abnormal megakaryocytes in the pathogenesis of pulmonary fibrosis ? : case reportsFACON, T; GOUDEMAND, J; CARON, C et al.British journal of haematology. 1990, Vol 74, Num 4, pp 542-543, issn 0007-1048, 2 p.Article

Leucémie aiguë lymphoblastique à cellules de Burkitt après maladie de Hodgkin: étude de deux observations = Burkitt cell leukemia following treatment of Hodgkin's disease. Study of two casesZANDECKI, M; DUPRIEZ, B; LAI, J.-L et al.Nouvelle revue française d'hématologie. 1987, Vol 29, Num 6, pp 365-369, issn 0029-4810Article

Modalités thérapeutiques du myélome multiple : Médecine interne-Oncologie = Therapeutic managements of multiple myelomaPASQUIER, F; MOREAU, A.-S; BIGNON, A et al.Réanimation (Paris. 2001). 2006, Vol 15, Num 4, pp 290-296, issn 1624-0693, 7 p.Article

Traitement du myélome multiple = The management of multiple myelomaLELEU, X; MOREAU, A.-S; GUIEZE, R et al.La Lettre du cancérologue (Boulogne). 2005, Vol 14, Num 1, pp 13-22, issn 1165-113X, 8 p.Article